201 related articles for article (PubMed ID: 23487024)
1. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
Conway AE; Scotland PB; Lavau CP; Wechsler DS
Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
[TBL] [Abstract][Full Text] [Related]
2. Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.
Suzuki M; Yamagata K; Shino M; Aikawa Y; Akashi K; Watanabe T; Kitabayashi I
Cancer Sci; 2014 Mar; 105(3):315-23. PubMed ID: 24397609
[TBL] [Abstract][Full Text] [Related]
3. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L.
Okada Y; Jiang Q; Lemieux M; Jeannotte L; Su L; Zhang Y
Nat Cell Biol; 2006 Sep; 8(9):1017-24. PubMed ID: 16921363
[TBL] [Abstract][Full Text] [Related]
4. A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias.
Conway AE; Haldeman JM; Wechsler DS; Lavau CP
Leukemia; 2015 Feb; 29(2):423-32. PubMed ID: 25027513
[TBL] [Abstract][Full Text] [Related]
5. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
[TBL] [Abstract][Full Text] [Related]
6. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
Archangelo LF; Gläsner J; Krause A; Bohlander SK
Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
[TBL] [Abstract][Full Text] [Related]
8. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias.
Lin YH; Kakadia PM; Chen Y; Li YQ; Deshpande AJ; Buske C; Zhang KL; Zhang Y; Xu GL; Bohlander SK
Blood; 2009 Jul; 114(3):651-8. PubMed ID: 19443658
[TBL] [Abstract][Full Text] [Related]
9. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
[TBL] [Abstract][Full Text] [Related]
10. Fusion of the CRM1 nuclear export receptor to AF10 causes leukemia and transcriptional activation of HOXA genes.
Aumann WK; Heath JL; Conway AE; Sze SK; Gupta VK; Kazi RR; Tope DR; Wechsler DS; Lavau CP
Leukemia; 2021 Mar; 35(3):876-880. PubMed ID: 32733011
[No Abstract] [Full Text] [Related]
11. Effects of iron depletion on CALM-AF10 leukemias.
Heath JL; Weiss JM; Lavau CP; Wechsler DS
Exp Hematol; 2014 Dec; 42(12):1022-1030.e1. PubMed ID: 25193880
[TBL] [Abstract][Full Text] [Related]
12. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
[TBL] [Abstract][Full Text] [Related]
13. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
Klein BJ; Deshpande A; Cox KL; Xuan F; Zandian M; Barbosa K; Khanal S; Tong Q; Zhang Y; Zhang P; Sinha A; Bohlander SK; Shi X; Wen H; Poirier MG; Deshpande AJ; Kutateladze TG
Nat Commun; 2021 Jul; 12(1):4130. PubMed ID: 34226546
[TBL] [Abstract][Full Text] [Related]
14. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
[TBL] [Abstract][Full Text] [Related]
15. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
[TBL] [Abstract][Full Text] [Related]
16. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes.
Dik WA; Brahim W; Braun C; Asnafi V; Dastugue N; Bernard OA; van Dongen JJ; Langerak AW; Macintyre EA; Delabesse E
Leukemia; 2005 Nov; 19(11):1948-57. PubMed ID: 16107895
[TBL] [Abstract][Full Text] [Related]
17. The CALM and CALM/AF10 interactor CATS is a marker for proliferation.
Archangelo LF; Greif PA; Hölzel M; Harasim T; Kremmer E; Przemeck GK; Eick D; Deshpande AJ; Buske C; de Angelis MH; Saad ST; Bohlander SK
Mol Oncol; 2008 Dec; 2(4):356-67. PubMed ID: 19383357
[TBL] [Abstract][Full Text] [Related]
18. The role of CALM-AF10 gene fusion in acute leukemia.
Caudell D; Aplan PD
Leukemia; 2008 Apr; 22(4):678-85. PubMed ID: 18094714
[TBL] [Abstract][Full Text] [Related]
19. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.
DiMartino JF; Ayton PM; Chen EH; Naftzger CC; Young BD; Cleary ML
Blood; 2002 May; 99(10):3780-5. PubMed ID: 11986236
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
